Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (original) (raw)

• Senapati, S. et al. Layered double hydroxides as effective carrier for anticancer drugs and tailoring of release rate through interlayer anions. J. Control. Release 224, 186–198 (2016).
  Article CAS PubMed Google Scholar
• Singh, N. K. et al. Nanostructure controlled anti-cancer drug delivery using poly (ε-caprolactone) based nanohybrids. J. Mater. Chem. 22, 17853–17863 (2012).
  Article CAS Google Scholar
• Singh, N. K. et al. CNT Induced β-phase in polylactide: unique crystallization, biodegradation, and biocompatibility. J. Phys. Chem. C. 117, 10163–10174 (2013).
  Article CAS Google Scholar
• Lombardo, D., Kiselev, M. A. & Caccamo, M. T. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J. Nanomater. 2019, 3702518 (2019).
• Mishra, A. et al. Self-assembled aliphatic chain extended polyurethane nanobiohybrids: Emerging hemocompatible biomaterials for sustained drug delivery. Acta Biomater. 10, 2133–2146 (2014).
  Article CAS PubMed Google Scholar
• Patel, D. K. et al. Influence of graphene on self-assembly of polyurethane and evaluation of its biomedical properties. Polymer 65, 183–192 (2015).
  Article CAS Google Scholar
• Senapati, S., Mahanta, A. K., Kumar, S. & Maiti, P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct. Target. Ther. 3, 7 (2018).
  Article PubMed PubMed Central CAS Google Scholar
• Kohane, D. S. & Langer, R. Biocompatibility and drug delivery systems. Chem. Sci. 1, 441–446 (2010).
  Article CAS Google Scholar
• Mahapatro, A. & Singh, D. K. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J. Nanobiotechnology 9, 55 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Maiti, P., Senapati, S. & Saraf, S. Inhibition of Chronic Osteomyelitis using Sustained Release of Drug from Biodegradable Polymeric Chip. Clin. Oncol. 3, 1406 (2018).
  Google Scholar
• Oberdörster, G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J. Intern. Med. 267, 89–105 (2010).
  Article PubMed CAS Google Scholar
• Patel, D. K. et al. Functionalized graphene tagged polyurethanes for corrosion inhibitor and sustained drug delivery. ACS Biomater. Sci. Eng. 3, 3351–3363 (2017).
  Article CAS PubMed Google Scholar
• Mahanta, A. K. et al. Polyurethane-grafted chitosan as new biomaterials for controlled drug delivery. Macromolecules 48, 2654–2666 (2015).
  Article CAS Google Scholar
• Moghimi, S. M., Hunter, A. C. & Murray, J. C. Nanomedicine: current status and future prospects. FASEB J. 19, 311–330 (2005).
  Article CAS PubMed Google Scholar
• Markman, J. L., Rekechenetskiy, A., Holler, E. & Ljubimova, J. Y. Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv. Drug Deliv. Rev. 65, 1866–1879 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Rizvi, S. A. & Saleh, A. M. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm. J. 26, 64–70 (2018).
  Article PubMed Google Scholar
• Sercombe, L. et al. Advances and challenges of liposome assisted drug delivery. Front. Pharmacol. 6, 286 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Ahmad, Z., Shah, A., Siddiq, M. & Kraatz, H.-B. Polymeric micelles as drug delivery vehicles. Rsc Adv. 4, 17028–17038 (2014).
  Article CAS Google Scholar
• Palmerston Mendes, L., Pan, J. & Torchilin, V. Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy. Molecules 22, 1401 (2017).
  Article PubMed Central CAS Google Scholar
• Kapusetti, G. et al. Bone cement based nanohybrid as a super biomaterial for bone healing. J. Mater. Chem. B 2, 3984–3997 (2014).
  Article CAS PubMed Google Scholar
• Sharma, A. & Sharma, U. S. Liposomes in drug delivery: progress and limitations. Int. J. Pharm. 154, 123–140 (1997).
  Article CAS Google Scholar
• Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R. & Rudzinski, W. E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70, 1–20 (2001).
  Article CAS PubMed Google Scholar
• Patra, J. K. et al. Nano based drug delivery systems: recent developments and future prospects. J. Nanobiotechnology 16, 71 (2018).
  Article PubMed PubMed Central CAS Google Scholar
• Biswas, A., Shukla, A. & Maiti, P. Biomaterials for interfacing cell imaging and drug delivery–an Overview. Langmuir (2019). https://doi.org/10.1021/acs.langmuir.9b00419.
• Ahmed, E. M. Hydrogel: Preparation, characterization, and applications: a review. J. Adv. Res. 6, 105–121 (2015).
  Article CAS PubMed Google Scholar
• Tabata, Y. Biomaterial technology for tissue engineering applications. J. R. Soc. interface 6, S311–S324 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, W., Jin, X., Cong, Y., Liu, Y. & Fu, J. Degradable natural polymer hydrogels for articular cartilage tissue engineering. J. Chem. Technol. Biotechnol. 88, 327–339 (2013).
  Article CAS Google Scholar
• Kiatkamjornwong, S. Superabsorbent polymers and superabsorbent polymer composites. Sci. Asia 33, 39–43 (2007).
  Article Google Scholar
• Ogata, T., Nagayoshi, K., Nagasako, T., Kurihara, S. & Nonaka, T. Synthesis of hydrogel beads having phosphinic acid groups and its adsorption ability for lanthanide ions. React. Funct. Polym. 66, 625–633 (2006).
  Article CAS Google Scholar
• Karadağ, E., Saraydın, D. & Güven, O. Radiation induced superabsorbent hydrogels. Acrylamide/itaconic acid copolymers. Macromol. Mater. Eng. 286, 34–42 (2001).
  Article Google Scholar
• Hoffman, A. S. Hydrogels for biomedical applications. Adv. Drug Deliv. Rev. 64, 18–23 (2012).
  Article Google Scholar
• Gaucher, G. et al. Block copolymer micelles: preparation, characterization and application in drug delivery. J. Control. Release 109, 169–188 (2005).
  Article CAS PubMed Google Scholar
• Rösler, A., Vandermeulen, G. W. & Klok, H.-A. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv. drug Deliv. Rev. 64, 270–279 (2012).
  Article Google Scholar
• Kataoka, K., Harada, A. & Nagasaki, Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. drug Deliv. Rev. 64, 37–48 (2012).
  Article Google Scholar
• Bae, Y., Fukushima, S., Harada, A. & Kataoka, K. Design of environment‐sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. 42, 4640–4643 (2003).
  Article CAS Google Scholar
• Schmaljohann, D. Thermo-and pH-responsive polymers in drug delivery. Adv. drug Deliv. Rev. 58, 1655–1670 (2006).
  Article CAS PubMed Google Scholar
• Vetvicka, D. et al. Biological evaluation of polymeric micelles with covalently bound doxorubicin. Bioconjugate Chem. 20, 2090–2097 (2009).
  Article CAS Google Scholar
• Watanabe, M. et al. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability. Int. J. Pharm. 308, 183–189 (2006).
  Article CAS PubMed Google Scholar
• Abbasi, E. et al. Dendrimers: synthesis, applications, and properties. Nanoscale Res. Lett. 9, 247 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Grayson, S. M. & Frechet, J. M. Convergent dendrons and dendrimers: from synthesis to applications. Chem. Rev. 101, 3819–3868 (2001).
  Article CAS PubMed Google Scholar
• Gillies, E. R. & Frechet, J. M. Dendrimers and dendritic polymers in drug delivery. Drug Discov. Today 10, 35–43 (2005).
  Article CAS PubMed Google Scholar
• Wiener, E. et al. Dendrimer‐based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn. Reson. Med. 31, 1–8 (1994).
  Article CAS PubMed Google Scholar
• Yiyun, C. et al. Transdermal delivery of nonsteroidal anti‐inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. J. Pharm. Sci. 96, 595–602 (2007).
  Article CAS Google Scholar
• Nishiyama, N. et al. Light-harvesting ionic dendrimer porphyrins as new photosensitizers for photodynamic therapy. Bioconjugate Chem. 14, 58–66 (2003).
  Article CAS Google Scholar
• Park, W. & Na, K. Advances in the synthesis and application of nanoparticles for drug delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnology 7, 494–508 (2015).
  Article CAS Google Scholar
• Elsabahy, M. & Wooley, K. L. Design of polymeric nanoparticles for biomedical delivery applications. Chem. Soc. Rev. 41, 2545–2561 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, S. C. et al. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J. Control. Release 72, 191–202 (2001).
  Article CAS PubMed Google Scholar
• Wang, Y., Shim, M. S., Levinson, N. S., Sung, H. W. & Xia, Y. Stimuli‐responsive materials for controlled release of theranostic agents. Adv. Funct. Mater. 24, 4206–4220 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Huh, K. M., Kang, H. C., Lee, Y. J. & Bae, Y. H. pH-sensitive polymers for drug delivery. Macromol. Res. 20, 224–233 (2012).
  Article CAS Google Scholar
• Rao, C., Matte, H. R., Voggu, R. & Govindaraj, A. Recent progress in the synthesis of inorganic nanoparticles. Dalton Trans. 41, 5089–5120 (2012).
  Article CAS PubMed Google Scholar
• Na, H. B., Song, I. C. & Hyeon, T. Inorganic nanoparticles for MRI contrast agents. Adv. Mater. 21, 2133–2148 (2009).
  Article CAS Google Scholar
• Anselmo, A. C. & Mitragotri, S. A review of clinical translation of inorganic nanoparticles. AAPS J. 17, 1041–1054 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Akbarzadeh, A. et al. Liposome: classification, preparation, and applications. Nanoscale Res. Lett. 8, 102 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Immordino, M. L., Dosio, F. & Cattel, L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomed. 1, 297 (2006).
  Article CAS Google Scholar
• Manzano, M. & Vallet-Regí, M. New developments in ordered mesoporous materials for drug delivery. J. Mater. Chem. 20, 5593–5604 (2010).
  Article CAS Google Scholar
• Zhao, P. et al. Synthesis and drug delivery applications for mesoporous silica nanoparticles. J. Med. Biotechnol. 1, 1–8 (2017).
• Fryxell, G. E. The synthesis of functional mesoporous materials. Inorg. Chem. Commun. 9, 1141–1150 (2006).
  Article CAS Google Scholar
• Yu, C., Fan, J., Tian, B., Stucky, G. D. & Zhao, D. Synthesis of mesoporous silica from commercial poly (ethylene oxide)/poly (butylene oxide) copolymers: toward the rational design of ordered mesoporous materials. J. Phys. Chem. B 107, 13368–13375 (2003).
  Article CAS Google Scholar
• Smith, I., Liu, X., Smith, L. & Ma, P. Nanostructured polymer scaffolds for tissue engineering and regenerative medicine. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnology 1, 226–236 (2009).
  Article CAS Google Scholar
• Biswas, A., Amarajeewa, M., Senapati, S., Sahu, M. & Maiti, P. Sustained release of herbal drugs using biodegradable scaffold for faster wound healing and better patient compliance. Nanomedicine 14, 2131–2141 (2018).
  Article CAS PubMed Google Scholar
• Ma, P. X. & Zhang, R. Synthetic nano‐scale fibrous extracellular matrix. J. Biomed. Mater. Res. 46, 60–72 (1999).
  Article CAS PubMed Google Scholar
• Zhang, R. & Ma, P. X. Synthetic nano-fibrillar extracellular matrices with predesigned macroporous architectures. J. Biomed. Mater. Res. 52, 430–438 (2000).
  Article CAS PubMed Google Scholar
• Zhang, R. & Ma, P. X. Biomimetic polymer/apatite composite scaffolds for mineralized tissue engineering. Macromol. Biosci. 4, 100–111 (2004).
  Article CAS PubMed Google Scholar
• Dutta, R. C., Dey, M., Dutta, A. K. & Basu, B. Competent processing techniques for scaffolds in tissue engineering. Biotechnol. Adv. 35, 240–250 (2017).
  Article CAS PubMed Google Scholar
• Hutmacher, D. W. in The biomaterials: Silver jubilee compendium 175–189 (Elsevier, 2000).
• Roseti, L. et al. Scaffolds for bone tissue engineering: state of the art and new perspectives. Mater. Sci. Eng.: C. 78, 1246–1262 (2017).
  Article CAS Google Scholar
• Eltom, A., Zhong, G. & Muhammad, A. Scaffold techniques and designs in tissue engineering functions and purposes: a review. Adv. Mater. Sci. Eng. 2019, 3429527 (2019).
• Chen, G., Ushida, T. & Tateishi, T. Scaffold design for tissue engineering. Macromol. Biosci. 2, 67–77 (2002).
  Article CAS Google Scholar
• Li, Z. et al. Recent progress in tissue engineering and regenerative medicine. J. Biomater. Tissue Eng. 6, 755–766 (2016).
  Article Google Scholar
• Veiseh, O., Tang, B. C., Whitehead, K. A., Anderson, D. G. & Langer, R. Managing diabetes with nanomedicine: challenges and opportunities. Nat. Rev. Drug Discov. 14, 45 (2015).
  Article CAS PubMed Google Scholar
• Misra, P., Upadhyay, R., Misra, A. & Anand, K. A review of the epidemiology of diabetes in rural India. Diabetes Res. Clin. Pract. 92, 303–311 (2011).
  Article CAS PubMed Google Scholar
• Alberti, K. G. M. M. & Zimmet, Pf Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional Rep. a WHO consultation. Diabet. Med. 15, 539–553 (1998).
  CAS Google Scholar
• Landon, M. B. et al. A multicenter, randomized trial of treatment for mild gestational diabetes. New Engl. J. Med. 361, 1339–1348 (2009).
  Article CAS PubMed Google Scholar
• García-Pérez, L.-E., Álvarez, M., Dilla, T., Gil-Guillén, V. & Orozco-Beltrán, D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 4, 175–194 (2013).
  Article PubMed PubMed Central Google Scholar
• Wadden, T. A. et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. New Engl. J. Med. 353, 2111–2120 (2005).
  Article CAS PubMed Google Scholar
• Meier, J. J. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat. Rev. Endocrinol. 8, 728 (2012).
  Article CAS PubMed Google Scholar
• Allison, S. D. Liposomal drug delivery. J. Infus. Nurs. 30, 89–95 (2007).
  Article PubMed Google Scholar
• Maurer, N., Fenske, D. B. & Cullis, P. R. Developments in liposomal drug delivery systems. Expert Opin. Biol. Ther. 1, 923–947 (2001).
  Article CAS PubMed Google Scholar
• Zhang, X. et al. Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicity. Nanoscale Res. Lett. 9, 185 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Wu, Z., Ping, Q., Wei, Y. & Lai, J. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice. Acta Pharmacologica Sin. 25, 966–972 (2004).
  CAS Google Scholar
• Agrawal, A. K., Harde, H., Thanki, K. & Jain, S. Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration. Biomacromolecules 15, 350–360 (2013).
  Article PubMed CAS Google Scholar
• Ag Seleci, D., Seleci, M., Walter, J.-G., Stahl, F. & Scheper, T. Niosomes as nanoparticular drug carriers: fundamentals and recent applications. J. Nanomater. 2016, 7372306 (2016).
• Ning, M., Guo, Y., Pan, H., Yu, H. & Gu, Z. Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats. Drug Deliv. 12, 399–407 (2005).
  Article CAS PubMed Google Scholar
• Hasan, A. A., Madkor, H. & Wageh, S. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Deliv. 20, 120–126 (2013).
  Article CAS PubMed Google Scholar
• Sharma, A. et al. Electrospun composite nanofiber-based transmucosal patch for anti-diabetic drug delivery. J. Mater. Chem. B 1, 3410–3418 (2013).
  Article CAS PubMed Google Scholar
• Jin, Y. et al. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 33, 1573–1582 (2012).
  Article CAS PubMed Google Scholar
• Chalasani, K. B., Russell-Jones, G. J., Jain, A. K., Diwan, P. V. & Jain, S. K. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. J. controlled release 122, 141–150 (2007).
  Article CAS Google Scholar
• Choi, W. I. et al. Efficient skin permeation of soluble proteins via flexible and functional nano-carrier. J. control. Release 157, 272–278 (2012).
  Article CAS PubMed Google Scholar
• Gates, R., Smith, R., Hunt, M. & Lazarus, N. Return to normal of blood-glucose, plasma-insulin, and weight gain in New Zealand obese mice after implantation of islets of Langerhans. Lancet 300, 567–570 (1972).
  Article Google Scholar
• Robertson, R. P. Islet transplantation as a treatment for diabetes—a work in progress. New Engl. J. Med. 350, 694–705 (2004).
  Article CAS PubMed Google Scholar
• Teramura, Y. & Iwata, H. Bioartificial pancreas: microencapsulation and conformal coating of islet of Langerhans. Adv. Drug Deliv. Rev. 62, 827–840 (2010).
  Article CAS PubMed Google Scholar
• Czech, M. P., Aouadi, M. & Tesz, G. J. RNAi-based therapeutic strategies for metabolic disease. Nature Reviews. Endocrinology 7, 473 (2011).
  CAS PubMed Google Scholar
• Li, F. & Mahato, R. I. RNA interference for improving the outcome of islet transplantation. Adv. drug Deliv. Rev. 63, 47–68 (2011).
  Article CAS PubMed Google Scholar
• Ko, K. S., Lee, M., Koh, J. J. & Kim, S. W. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. Mol. Ther. 4, 313–316 (2001).
  Article CAS PubMed Google Scholar
• Desai, A. K. & Grossberg, G. T. Diagnosis and treatment of Alzheimer’s disease. Neurology 64, S34–S39 (2005).
  Article CAS PubMed Google Scholar
• Nussbaum, R. L. & Ellis, C. E. Alzheimer’s disease and Parkinson’s disease. New Engl. J. Med. 348, 1356–1364 (2003).
  Article CAS PubMed Google Scholar
• Hernando, S. et al. Advances in nanomedicine for the treatment of Alzheimer’s and Parkinson’s diseases. Nanomedicine 11, 1267–1285 (2016).
  Article CAS PubMed Google Scholar
• Bentley, P., Driver, J. & Dolan, R. J. Modulation of fusiform cortex activity by cholinesterase inhibition predicts effects on subsequent memory. Brain 132, 2356–2371 (2009).
  Article CAS PubMed Google Scholar
• Molinuevo, J. L., Lladó, A. & Rami, L. Memantine: targeting glutamate excitotoxicity in Alzheimer’s disease and other dementias. Am. J. Alzheimer’s. Dis. Other Demen. 20, 77–85 (2005).
  Article Google Scholar
• Joshi, S. A., Chavhan, S. S. & Sawant, K. K. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur. J. Pharm. Biopharm. 76, 189–199 (2010).
  Article CAS PubMed Google Scholar
• Wilson, B. et al. Poly (n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer’s disease. Brain Res. 1200, 159–168 (2008).
  Article CAS PubMed Google Scholar
• Nagpal, K., Singh, S. & Mishra, D. Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety. Int. J. Biol. Macromol. 59, 72–83 (2013).
  Article CAS PubMed Google Scholar
• Bhavna et al. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug Dev. Ind. Pharm. 40, 278–287 (2014).
  Article CAS Google Scholar
• Misra, S., Chopra, K., Sinha, V. & Medhi, B. Galantamine-loaded solid–lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations. Drug Deliv. 23, 1434–1443 (2016).
  Article CAS PubMed Google Scholar
• Mufamadi, M. S. et al. Ligand-functionalized nanoliposomes for targeted delivery of galantamine. Int. J. Pharm. 448, 267–281 (2013).
  Article CAS PubMed Google Scholar
• Laserra, S. et al. Solid lipid nanoparticles loaded with lipoyl–memantine codrug: preparation and characterization. Int. J. Pharm. 485, 183–191 (2015).
  Article CAS PubMed Google Scholar
• Herran, E. et al. Enhanced hippocampal neurogenesis in APP/Ps1 mouse model of Alzheimer’s disease after implantation of VEGF-loaded PLGA nanospheres. Curr. Alzheimer Res. 12, 932–940 (2015).
  Article CAS PubMed Google Scholar
• Kurakhmaeva, K. B. et al. Brain targeting of nerve growth factor using poly (butyl cyanoacrylate) nanoparticles. J. Drug Target. 17, 564–574 (2009).
  Article CAS PubMed Google Scholar
• Kuo, Y.-c & Lin, C.-C. Rescuing apoptotic neurons in Alzheimer’s disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin. Int. J. Nanomed. 10, 2653 (2015).
  Article CAS Google Scholar
• Kuo, Y.-C. & Chou, P.-R. Neuroprotection against degeneration of SK-N-MC cells using neuron growth factor-encapsulated liposomes with surface cereport and transferrin. J. Pharm. Sci. 103, 2484–2497 (2014).
  Article CAS PubMed Google Scholar
• Frozza, R. L. et al. Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules. Mol. Neurobiol. 47, 1066–1080 (2013).
  Article CAS PubMed Google Scholar
• Meng, F. et al. A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer’s disease. Colloids Surf. B: Biointerfaces 134, 88–97 (2015).
  Article CAS PubMed Google Scholar
• Coradini, K. et al. Co-encapsulation of resveratrol and curcumin in lipid-core nanocapsules improves their in vitro antioxidant effects. Eur. J. Pharm. Biopharm. 88, 178–185 (2014).
  Article CAS PubMed Google Scholar
• Cano, A. et al. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer’s disease mice model. J. Control. Release. 301, 62–75 (2019).
  Article CAS PubMed PubMed Central Google Scholar
• Garbayo, E., Ansorena, E. & Blanco-Prieto, M. J. Drug development in Parkinson’s disease: from emerging molecules to innovative drug delivery systems. Maturitas 76, 272–278 (2013).
  Article CAS PubMed Google Scholar
• Trapani, A. et al. Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery. Int. J. Pharm. 419, 296–307 (2011).
  Article CAS PubMed Google Scholar
• Pillay, S. et al. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain. Int. J. Pharm. 382, 277–290 (2009).
  Article CAS PubMed Google Scholar
• López, T. et al. Treatment of Parkinson’s disease: nanostructured sol–gel silica–dopamine reservoirs for controlled drug release in the central nervous system. Int. J. Nanomed. 6, 19 (2011).
  Article Google Scholar
• D’Aurizio, E. et al. Biodegradable microspheres loaded with an anti-Parkinson prodrug: an in vivo pharmacokinetic study. Mol. Pharm. 8, 2408–2415 (2011).
  Article PubMed CAS Google Scholar
• Ren, T. et al. Sustained-release formulation of levodopa methyl ester/benserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned rats. Neurosci. Lett. 502, 117–122 (2011).
  Article CAS PubMed Google Scholar
• Yang, X. et al. Controlled-release levodopa methyl ester/benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats. Int. J. Nanomed. 7, 2077 (2012).
  CAS Google Scholar
• Wang, A. et al. Preparation of rotigotine-loaded microspheres and their combination use with L-DOPA to modify dyskinesias in 6-OHDA-lesioned rats. Pharm. Res. 29, 2367–2376 (2012).
  Article CAS PubMed Google Scholar
• Ye, L. et al. Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in SD rats. Food Chem. Toxicol. 56, 81–92 (2013).
  Article CAS PubMed Google Scholar
• Tian, J. et al. Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in Cynomolgus monkeys. Food Chem. Toxicol. 52, 143–152 (2013).
  Article CAS PubMed Google Scholar
• Azeem, A. et al. Oil based nanocarrier system for transdermal delivery of ropinirole: a mechanistic, pharmacokinetic and biochemical investigation. Int. J. pharmaceutics 422, 436–444 (2012).
  Article CAS Google Scholar
• Pardeshi, C. V., Rajput, P. V., Belgamwar, V. S., Tekade, A. R. & Surana, S. J. Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach. Drug Deliv. 20, 47–56 (2013).
  Article CAS PubMed Google Scholar
• Tsai, M.-J. et al. Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations. J. Pharm. Sci. 100, 547–557 (2011).
  Article CAS PubMed Google Scholar
• Esposito, E. et al. Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm. Res. 25, 1521–1530 (2008).
  Article CAS PubMed Google Scholar
• Jollivet, C. et al. Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson’s disease. Neurosci. Lett. 356, 207–210 (2004).
  Article CAS PubMed Google Scholar
• Garbayo, E. et al. Effective GDNF brain delivery using microspheres—a promising strategy for Parkinson’s disease. J. Controlled Release 135, 119–126 (2009).
  Article CAS Google Scholar
• Gujral, C., Minagawa, Y., Fujimoto, K., Kitano, H. & Nakaji-Hirabayashi, T. Biodegradable microparticles for strictly regulating the release of neurotrophic factors. J. Control. Release 168, 307–316 (2013).
  Article CAS PubMed Google Scholar
• Saraiva, C., Paiva, J., Santos, T., Ferreira, L. & Bernardino, L. MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson’s disease. J. Control. Release 235, 291–305 (2016).
  Article CAS PubMed Google Scholar
• Alam, T. et al. Nanocarriers as treatment modalities for hypertension. Drug Deliv. 24, 358–369 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Martín Giménez, V. M., Kassuha, D. E. & Manucha, W. Nanomedicine applied to cardiovascular diseases: latest developments. Ther. Adv. cardiovasc. Dis. 11, 133–142 (2017).
  Article PubMed PubMed Central CAS Google Scholar
• Mutschler, E. & Knauf, H. Current status of sustained release formulations in the treatment of hypertension. Clin. Pharmacogenet. 37, 1–6 (1999).
  Article CAS Google Scholar
• Katz, B., Rosenberg, A. & Frishman, W. H. Controlled-release drug delivery systems in cardiovascular medicine. Am. Heart J. 129, 359–368 (1995).
  Article CAS PubMed Google Scholar
• Koziolek, M. et al. Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the Intellicap® system. J. Pharm. Sci. 104, 2855–2863 (2015).
  Article CAS PubMed Google Scholar
• Desai, P. P., Date, A. A. & Patravale, V. B. Overcoming poor oral bioavailability using nanoparticle formulations–opportunities and limitations. Drug Discov. Today. Technol. 9, e87–e95 (2012).
  Article CAS Google Scholar
• Nepolean, R., Narayanan, N., Subramaniyan, N., Venkateswaran, K. & Vinoth, J. Colon targeted methacrylic acid copolymeric nanoparticles for improved oral bioavailability of nisoldipine. Int. J. Biol. Pharm. Res. 3, 962–967 (2012).
  Google Scholar
• Shah, U., Joshi, G. & Sawant, K. Improvement in antihypertensive and antianginal effects of felodipine by enhanced absorption from PLGA nanoparticles optimized by factorial design. Mater. Sci. Eng.: C. 35, 153–163 (2014).
  Article CAS Google Scholar
• Arora, A. et al. Development of sustained release “nanofdc (fixed dose combination)” for hypertension–an experimental study. PLoS ONE 10, e0128208 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Antal, I. et al. Magnetic poly (D, L-lactide) nanoparticles loaded with aliskiren: a promising tool for hypertension treatment. J. Magn. Magn. Mater. 380, 280–284 (2015).
  Article CAS Google Scholar
• Kim, Y. I. et al. The antihypertensive effect of orally administered nifedipine‐loaded nanoparticles in spontaneously hypertensive rats. Br. J. Pharmacol. 120, 399–404 (1997).
  Article CAS PubMed Google Scholar
• Mallion, J.-M., Asmar, R., Boutelant, S. & Guez, D. Twenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: results of two randomized double-blind controlled studies. J. Cardiovascular Pharmacol. 32, 673–678 (1998).
  Article CAS Google Scholar
• Suzuki, H., Noda, Y., Paul, S., Gao, X.-p & Rubinstein, I. Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation in vivo. Life Sci. 57, 1451–1457 (1995).
  Article CAS PubMed Google Scholar
• Rubinstein, I., Ikezaki, H. & Önyüksel, H. Intratracheal and subcutaneous liposomal VIP normalizes arterial pressure in spontaneously hypertensive hamsters. Int. J. pharmaceutics 316, 144–147 (2006).
  Article CAS Google Scholar
• Deshpande, P. B. et al. A novel nanoproliposomes of lercanidipine: Development, in vitro and preclinical studies to support its effectiveness in hypertension therapy. Life Sci. 162, 125–137 (2016).
  Article CAS PubMed Google Scholar
• Mariangela de Burgos, Md et al. New formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles. Int. J. Nanomed. 6, 1005 (2011).
  Google Scholar
• Mendes, C. et al. Inclusion complexes of hydrochlorothiazide and β-cyclodextrin: Physicochemical characteristics, in vitro and in vivo studies. Eur. J. Pharm. Sci. 83, 71–78 (2016).
  Article CAS PubMed Google Scholar
• Nolte, A., Schneider, M., Walker, T. & Wendel, H. in Regenerative Medicine and Tissue Engineering-Cells and Biomaterials (IntechOpen, 2011).
• Hyafil, F. et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat. Med. 13, 636 (2007).
  Article CAS PubMed Google Scholar
• Weissleder, R., Nahrendorf, M. & Pittet, M. J. Imaging macrophages with nanoparticles. Nat. Mater. 13, 125 (2014).
  Article CAS PubMed Google Scholar
• Morishige, K. et al. High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis. Circulation 122, 1707–1715 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Lewis, D. R. et al. Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo. Proc. Natl Acad. Sci. USA 112, 2693–2698 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Jun, Y.-w. et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J. Am. Chem. Soc. 127, 5732–5733 (2005).
  Article CAS PubMed Google Scholar
• Tyler, B., Gullotti, D., Mangraviti, A., Utsuki, T. & Brem, H. Polylactic acid (PLA) controlled delivery carriers for biomedical applications. Adv. Drug Deliv. Rev. 107, 163–175 (2016).
  Article CAS PubMed Google Scholar
• Katsuki, S. et al. Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes. Circulation 129, 896–906 (2014).
  Article CAS PubMed Google Scholar
• Leuschner, F. et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat. Biotechnol. 29, 1005 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Takahama, H. et al. Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats. J. Am. Coll. Cardiol. 53, 709–717 (2009).
  Article CAS PubMed Google Scholar
• Hausenloy, D. J. & Yellon, D. M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Investig. 123, 92–100 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Matoba, T. & Egashira, K. Nanoparticle-mediated drug delivery system for cardiovascular disease. Int. heart J. 55, 281–286 (2014).
  Article CAS PubMed Google Scholar
• Yajima, S. et al. Prostacyclin analogue–loaded nanoparticles attenuate myocardial Ischemia/reperfusion Injury in rats. JACC: Basic Transl. Sci. 4, 318–331 (2019).
  PubMed PubMed Central Google Scholar
• Bailey, M. M. & Berkland, C. J. Nanoparticle formulations in pulmonary drug delivery. Medicinal Res. Rev. 29, 196–212 (2009).
  Article CAS Google Scholar
• Liechty, W. B., Kryscio, D. R., Slaughter, B. V. & Peppas, N. A. Polymers for drug delivery systems. Annu. Rev. Chem. biomolecular Eng. 1, 149–173 (2010).
  Article CAS Google Scholar
• Beck-Broichsitter, M., Merkel, O. M. & Kissel, T. Controlled pulmonary drug and gene delivery using polymeric nano-carriers. J. controlled release 161, 214–224 (2012).
  Article CAS Google Scholar
• Cooper, V. et al. Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study. NPJ Prim. Care Respir. Med. 25, 15026 (2015).
  Article PubMed PubMed Central Google Scholar
• Barnes, P. J. Severe asthma: advances in current management and future therapy. J. Allergy Clin. Immunol. 129, 48–59 (2012).
  Article CAS PubMed Google Scholar
• SILVA, A. L. et al. Nanoparticle-based therapy for respiratory diseases. An. da Academia Brasileira de. Ciências 85, 137–146 (2013).
  Article Google Scholar
• Kolte, A., Patil, S., Lesimple, P., Hanrahan, J. W. & Misra, A. PEGylated composite nanoparticles of PLGA and polyethylenimine for safe and efficient delivery of pDNA to lungs. Int. J. pharmaceutics 524, 382–396 (2017).
  Article CAS Google Scholar
• Schneider, C. S. et al. Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation. Sci. Adv. 3, e1601556 (2017).
  Article PubMed PubMed Central CAS Google Scholar
• Chen, X. et al. Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery. Int. J. Nanomed. 7, 1139 (2012).
  CAS Google Scholar
• Wang, W. et al. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int. J. Nanomed. 7, 3667 (2012).
  Article CAS Google Scholar
• Patil-Gadhe, A., Kyadarkunte, A., Patole, M. & Pokharkar, V. Montelukast-loaded nanostructured lipid carriers: part II pulmonary drug delivery and in vitro–in vivo aerosol performance. Eur. J. Pharm. Biopharm. 88, 169–177 (2014).
  Article CAS PubMed Google Scholar
• Patil-Gadhe, A. & Pokharkar, V. Montelukast-loaded nanostructured lipid carriers: part I oral bioavailability improvement. Eur. J. Pharm. Biopharm. 88, 160–168 (2014).
  Article CAS PubMed Google Scholar
• Morris, A. S. et al. Cationic CaMKII inhibiting nanoparticles prevent allergic asthma. Mol. Pharm. 14, 2166–2175 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Jackson, J. K., Zhang, X., Llewellen, S., Hunter, W. L. & Burt, H. M. The characterization of novel polymeric paste formulations for intratumoral delivery. Int. J. Pharm. 270, 185–198 (2004).
  Article CAS PubMed Google Scholar
• Kenyon, N. J. et al. Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation. PLoS ONE 8, e77730 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Di Gioia, S. et al. Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier. Pulm. Pharmacol. Ther. 34, 8–24 (2015).
  Article PubMed CAS Google Scholar
• Köping-Höggård, M. et al. Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. 8, 1108 (2001).
  Article PubMed Google Scholar
• Bivas-Benita, M. et al. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA–PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. Vaccine 27, 4010–4017 (2009).
  Article CAS PubMed Google Scholar
• Kumar, M. et al. Chitosan IFN-γ-pDNA nanoparticle (CIN) therapy for allergic asthma. Genet. Vaccines Ther. 1, 3 (2003).
  Article PubMed PubMed Central Google Scholar
• Da Silva, A. L. et al. DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma. J. Control. Release 180, 125–133 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Mastorakos, P. et al. Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy. Proc. Natl Acad. Sci. USA 112, 8720–8725 (2015).
  Article CAS Google Scholar
• Vogelmeier, C. F. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am. J. Respir. Crit. Care Med. 195, 557–582 (2017).
  Article CAS PubMed Google Scholar
• Vij, N. Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential. Expert Opin. Drug Deliv. 8, 1105–1109 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Muralidharan, P., Hayes, D., Black, S. M. & Mansour, H. M. Microparticulate/nanoparticulate powders of a novel Nrf2 activator and an aerosol performance enhancer for pulmonary delivery targeting the lung Nrf2/Keap-1 pathway. Mol. Syst. Des. Eng. 1, 48–65 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Roulet, A. et al. Intratracheally administered titanium dioxide or carbon black nanoparticles do not aggravate elastase-induced pulmonary emphysema in rats. BMC Pulm. Med. 12, 38 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Geiser, M. et al. Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease. Part. Fibre Toxicol. 10, 19 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Al Faraj, A., Shaik, A. S., Afzal, S., Al Sayed, B. & Halwani, R. MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles. Int. J. Nanomed. 9, 1491 (2014).
  Article Google Scholar
• Vij, N., Min, T., Bodas, M., Gorde, A. & Roy, I. Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases. Nanomed.: Nanotechnol., Biol. Med. 12, 2415–2427 (2016).
  Article CAS Google Scholar
• Gagneux, S. Host–pathogen coevolution in human tuberculosis. Philos. Trans. R. Soc. B: Biol. Sci. 367, 850–859 (2012).
  Article CAS Google Scholar
• Rappuoli, R. & Aderem, A. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 473, 463 (2011).
  Article CAS PubMed Google Scholar
• Sia, I. G. & Wieland, M. L. in Mayo Clinic Proceedings. 348–361 (Elsevier).
• Aderem, A. & Underhill, D. M. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17, 593–623 (1999).
  Article CAS PubMed Google Scholar
• Krishnan, N., Robertson, B. D. & Thwaites, G. The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis. Tuberculosis 90, 361–366 (2010).
  Article CAS PubMed Google Scholar
• Pham, D.-D., Fattal, E. & Tsapis, N. Pulmonary drug delivery systems for tuberculosis treatment. Int. J. pharmaceutics 478, 517–529 (2015).
  Article CAS Google Scholar
• Andrade, F. et al. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Adv. drug Deliv. Rev. 65, 1816–1827 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Ahmad, S. & Mokaddas, E. Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis. J. Infect. Public Health 7, 75–91 (2014).
  Article PubMed Google Scholar
• Sarkar, S. & Suresh, M. R. An overview of tuberculosis chemotherapy–a literature review. J. Pharm. Pharm. Sci. 14, 148–161 (2011).
  Article CAS PubMed Google Scholar
• Tadolini, M. et al. First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline. Eur. Respiratory J. 48, 935–938 (2016).
  Article Google Scholar
• Wallis, R. S. & Hafner, R. Advancing host-directed therapy for tuberculosis. Nat. Rev. Immunol. 15, 255 (2015).
  Article CAS PubMed Google Scholar
• Willis, L., Hayes, D. & Mansour, H. M. Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery. Lung 190, 251–262 (2012).
  Article CAS PubMed Google Scholar
• Mortensen, N. P., Durham, P. & Hickey, A. J. The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy. J. Microencapsul. 31, 785–795 (2014).
  Article CAS PubMed Google Scholar
• Clemens, D. L. et al. Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles. Antimicrobial Agents Chemother. 56, 2535–2545 (2012).
  Article CAS Google Scholar
• Ferron, G. Aerosol properties and lung deposition. Eur. Respiratory J. 7, 1392–1394 (1994).
  Article CAS Google Scholar
• Gill, S. et al. Nanoparticles: characteristics, mechanisms of action, and toxicity in pulmonary drug delivery—a review. J. Biomed. Nanotechnol. 3, 107–119 (2007).
  Article CAS Google Scholar
• Finlay, W. & Wong, J. Regional lung deposition of nebulized liposome-encapsulated ciprofloxacin. Int. J. pharmaceutics 167, 121–127 (1998).
  Article CAS Google Scholar
• Bhavane, R., Karathanasis, E. & Annapragada, A. V. Triggered release of ciprofloxacin from nanostructured agglomerated vesicles. Int. J. Nanomed. 2, 407 (2007).
  Article CAS Google Scholar
• Chimote, G. & Banerjee, R. Evaluation of antitubercular drug‐loaded surfactants as inhalable drug‐delivery systems for pulmonary tuberculosis. J. Biomed. Mater. Res. A. 89, 281–292 (2009).
  Article CAS PubMed Google Scholar
• Gaur, P. K. et al. Targeted drug delivery of Rifampicin to the lungs: formulation, characterization, and stability studies of preformed aerosolized liposome and in situ formed aerosolized liposome. Drug Dev. Ind. Pharm. 36, 638–646 (2010).
  Article CAS PubMed Google Scholar
• Patil, J. S., Devi, V. K., Devi, K. & Sarasija, S. A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis. Lung India. 32, 331 (2015).
  Article PubMed PubMed Central Google Scholar
• Deol, P., Khuller, G. & Joshi, K. Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice. Antimicrobial Agents Chemother. 41, 1211–1214 (1997).
  Article CAS Google Scholar
• Videira, M. A. et al. Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J. drug Target. 10, 607–613 (2002).
  Article CAS PubMed Google Scholar
• Yu, W., Liu, C., Liu, Y., Zhang, N. & Xu, W. Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm. Res. 27, 1584–1596 (2010).
  Article CAS PubMed Google Scholar
• Jain, D. & Banerjee, R. Comparison of ciprofloxacin hydrochloride‐loaded protein, lipid, and chitosan nanoparticles for drug delivery. J. Biomed. Mater. Res. B: Appl. Biomater. 86, 105–112 (2008).
  Article CAS Google Scholar
• Nimje, N. et al. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting. J. Drug Target. 17, 777–787 (2009).
  Article CAS PubMed Google Scholar
• Pandey, R. & Khuller, G. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis 85, 227–234 (2005).
  Article CAS PubMed Google Scholar
• Chuan, J. et al. Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles. J. Nanopart. Res. 15, 1634 (2013).
  Article Google Scholar
• Chew, S. A. & Danti, S. Biomaterial-Based Implantable Devices for Cancer Therapy. Adv. Healthc. Mater. 6, 1600766 (2017).
  Article CAS Google Scholar
• Kumar, S., Singh, A. P., Senapati, S. & Maiti, P. Controlling Drug Delivery Using Nanosheet-Embedded Electrospun Fibers for Efficient Tumor Treatment. ACS Appl. Bio Mater. 2, 884–894 (2019).
  Article CAS PubMed Google Scholar
• Su, J., Chen, F., Cryns, V. L. & Messersmith, P. B. Catechol polymers for pH-responsive, targeted drug delivery to cancer cells. J. Am. Chem. Soc. 133, 11850–11853 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Dong, Y. et al. Lipid-Like Nanomaterials for Simultaneous Gene Expression and Silencing In Vivo. Adv. Healthc. Mater. 3, 1392–1397 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Shih, H. & Lin, C.-C. Photoclick hydrogels prepared from functionalized cyclodextrin and poly (ethylene glycol) for drug delivery and in situ cell encapsulation. Biomacromolecules 16, 1915–1923 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Sun, W. & Gu, Z. Engineering DNA scaffolds for delivery of anticancer therapeutics. Biomater. Sci. 3, 1018–1024 (2015).
  Article CAS PubMed Google Scholar
• Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751 (2007).
  Article CAS PubMed Google Scholar
• Patri, A. K., Kukowska-Latallo, J. F. & Baker, J. R. Jr. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv. drug Deliv. Rev. 57, 2203–2214 (2005).
  Article CAS PubMed Google Scholar
• Yuan, F. et al. Mirovascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res. 54, 3352–3356 (1994).
  CAS PubMed Google Scholar
• Zensi, A. et al. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J. Controlled Release. 137, 78–86 (2009).
  Article CAS Google Scholar
• Moghimi, S. M., Hunter, A. C. & Murray, J. C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53, 283–318 (2001).
  CAS PubMed Google Scholar
• Guan, J, He, H, Yu, B. & Lee, L. J. Polymeric nanoparticles and nanopore membranes for controlled drug and gene delivery. Biomedical Nanostructures 115–137 (Wiley-Interscience: Hoboken, NJ, 2007).
• Senapati, S. et al. Engineered cellular uptake and controlled drug delivery using two dimensional nanoparticle and polymer for cancer treatment. Mol. Pharm. 15, 679–694 (2018).
  Article CAS PubMed Google Scholar
• Perez, C. et al. Poly (lactic acid)-poly (ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J. Control. Release 75, 211–224 (2001).
  Article CAS PubMed Google Scholar
• Langer, R. New methods of drug delivery. Science 249, 1527–1533 (1990).
  Article CAS PubMed Google Scholar
• Langer, R. Drug delivery and targeting. Nature, 392, 5–10 (1998).
• Langer, R. & Folkman, J. Polymers for the sustained release of proteins and other macromolecules. Nature 263, 797 (1976).
  Article CAS PubMed Google Scholar
• Ferrari, M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 5, 161 (2005).
  Article CAS PubMed Google Scholar
• Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4, 145 (2005).
  Article CAS PubMed Google Scholar
• Ogawara, K.-i, Un, K., Tanaka, K.-i, Higaki, K. & Kimura, T. In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells. J. Control. Release 133, 4–10 (2009).
  Article CAS PubMed Google Scholar
• Ruttala, H. B. & Ko, Y. T. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Colloids Surf. B: Biointerfaces 128, 419–426 (2015).
  Article CAS PubMed Google Scholar
• Cao, J. et al. A7RC peptide modified paclitaxel liposomes dually target breast cancer. Biomater. Sci. 3, 1545–1554 (2015).
  Article CAS PubMed Google Scholar
• Sadava, D., Coleman, A. & Kane, S. E. Liposomal daunorubicin overcomes drug resistance in human breast, ovarian and lung carcinoma cells. J. liposome Res. 12, 301–309 (2002).
  Article CAS PubMed Google Scholar
• Andresen, T. L., Jensen, S. S. & Jørgensen, K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog. lipid Res. 44, 68–97 (2005).
  Article CAS PubMed Google Scholar
• Jesús, PadillaDe, Ihre, O. L., Gagne, H. R., Fréchet, L., Szoka, J. M. J. & Polyester, F. C. Dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconjugate Chem. 13, 453–461 (2002).
  Article CAS Google Scholar
• Zhong, Q. et al. Conjugation to poly(amidoamine) dendrimers and pulmonary delivery reduce cardiac accumulation and enhance antitumor activity of doxorubicin in lung metastasis. Mol. Pharm. 13, 2363–2375 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Li, H.-J. et al. Smart superstructures with ultrahigh pH-sensitivity for targeting acidic tumor microenvironment: instantaneous size switching and improved tumor penetration. ACS nano 10, 6753–6761 (2016).
  Article CAS PubMed Google Scholar
• Park, J. H. et al. Polymeric nanomedicine for cancer therapy. Prog. Polym. Sci. 33, 113–137 (2008).
  Article CAS Google Scholar
• Shi, C. et al. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles. Biomaterials 35, 8711–8722 (2014).
  Article CAS PubMed Google Scholar
• Kumari, P. et al. Cholesterol-conjugated poly(D, L-lactide)-based micelles as a nanocarrier system for effective delivery of curcumin in cancer therapy. Drug Deliv. 24, 209–223 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Wan, X. et al. Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments. Biomaterials 192, 1–14 (2019).
  Article CAS PubMed Google Scholar
• Peppas, N., Bures, P., Leobandung, W. & Ichikawa, H. Hydrogels in pharmaceutical formulations. Eur. J. pharmaceutics biopharmaceutics 50, 27–46 (2000).
  Article CAS Google Scholar
• Mahanta, A. K., Senapati, S. & Maiti, P. A polyurethane–chitosan brush as an injectable hydrogel for controlled drug delivery and tissue engineering. Polym. Chem. 8, 6233–6249 (2017).
  Article CAS Google Scholar
• Mahanta, A. K. et al. Nanoparticle-induced controlled drug delivery using chitosan-based hydrogel and scaffold: application to bone regeneration. Mol. Pharm. 16, 327–338 (2018).
  Article PubMed CAS Google Scholar
• Yu, J., Ha, W., Sun, J.-n & Shi, Y.-p Supramolecular hybrid hydrogel based on host–guest interaction and its application in drug delivery. ACS Appl. Mater. Interfaces 6, 19544–19551 (2014).
  Article CAS PubMed Google Scholar
• Chen, Y.-Y., Wu, H.-C., Sun, J.-S., Dong, G.-C. & Wang, T.-W. Injectable and thermoresponsive self-assembled nanocomposite hydrogel for long-term anticancer drug delivery. Langmuir 29, 3721–3729 (2013).
  Article CAS PubMed Google Scholar
• Shukla, A. et al. Efficacy of polyurethane graft on cyclodextrin to control drug release for tumor treatment. J. colloid Interface Sci. 534, 215–227 (2019).
  Article CAS PubMed Google Scholar
• Shukla, A., Singh, A. P., Dubey, T., Hemalatha, S. & Maiti, P. Third Generation Cyclodextrin Graft with Polyurethane Embedded in Hydrogel for a Sustained Drug Release: Complete Shrinkage of Melanoma. ACS Appl. Bio Mater. 2, 1762–1771 (2019).
  Article CAS PubMed Google Scholar